2,975.43
82,429.9
3.74%
Market Closed
1,436.55
4.27%
1,957.55
3.62%
178.1
3,620.3
5.17%
1,874.9
1.44%
1,449.7
4.39%
22.2
801.6
2.85%
119.25
1,626.7
7.91%
2,381
2.02%
9,009
4.27%
12
435.5
2.83%
815.2
3.61%
3,586.6
4.09%
1,669.65
6.35%
1,686.25
-3.36%
2,145
1.96%
12,615.4
2.96%
3,104.5
4.08%
1,204.1
4.4%
11,748
3.29%
14.55
349.15
4.35%
2,050.6
4.08%
3,566
1.57%
4,439.7
-1.36%
9.25
244
3.94%
1,362.95
4.27%
309.05
3.17%
720.55
1.7%
2,424.65
7.68%
4,023.85
1.27%
15.5
257.4
6.41%
395.45
3.35%
1,005.1
5.04%
322.8
2.23%
60.9
2,384.7
2.62%
2,354.1
2.34%
239.85
5.68%
8,044
4.69%
546.45
6.42%
142.35
1.71%
5,500
7.84%
332.2
5,446.35
6.5%
2,736.1
3.89%
151.55
6.16%
434.7
6.52%
1,746.35
2.78%
513.7
3.51%
28.05
435.9
6.88%
5,950
-0.85%
262.9
5.97%
49.75
681.25
7.88%
2975.43
82429.9
3.74%
Market Closed

CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
Bharat Forge Ltd. 25/07/20241,593.85952.3007/04/2025 -40.25% 256 days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

Unichem Labs gets USFDA nod to market generic version of Otezla; stock ends 5 per cent higher
DSIJ Intelligence
/ Categories: Trending, DSIJ News

Unichem Labs gets USFDA nod to market generic version of Otezla; stock ends 5 per cent higher

Unichem Laboratories Ltd, an international, integrated, speciality pharmaceutical company informed the exchanges on Friday that it has received ANDA approval for its Apremilast tablets in the strengths of 10 mg, 20 mg & 30 mg by United States Food & Drug Administration (USFDA).  

The abovementioned drug is the generic version of Amgen’s Otezla (Apremilast) tablets, 10 mg, 20 mg, and 30 mg. It is used for the treatment of adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy.  

Unichem Laboratories is engaged in the manufacturing and marketing of a large basket of pharmaceutical formulations as branded generics as well as generics in several markets across the world.  

Reacting to the news, the stock of Unichem Laboratories closed at Rs 320.70 per share on Friday, up by 4.94 per cent or 15.10 per share, against a 0.85 per cent decline in the benchmark index. The 52-week high is recorded at Rs 332.40 while its 52-week low is Rs 75.10 on BSE.   

Previous Article Bears dominate Sensex & Nifty; Tejas Networks gains 9 per cent, KRBL jumps 8 per cent, ONGC slips, PSU Bank index sheds 5 per cent
Next Article 2.9 How Are The Stock Prices Decided?
Print
1254 Rate this article:
5.0
Please login or register to post comments.

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR